S.A. Mason LLC Decreases Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

S.A. Mason LLC reduced its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 73.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 745 shares of the company’s stock after selling 2,061 shares during the period. S.A. Mason LLC’s holdings in GE HealthCare Technologies were worth $58,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Family Legacy Inc. grew its stake in GE HealthCare Technologies by 11.4% during the 4th quarter. Family Legacy Inc. now owns 11,891 shares of the company’s stock worth $919,000 after buying an additional 1,217 shares during the last quarter. Tandem Wealth Advisors LLC acquired a new stake in GE HealthCare Technologies during the 4th quarter worth about $322,000. Bar Harbor Wealth Management boosted its position in shares of GE HealthCare Technologies by 6.8% in the fourth quarter. Bar Harbor Wealth Management now owns 25,142 shares of the company’s stock worth $1,944,000 after buying an additional 1,590 shares during the period. Alhambra Investment Management LLC grew its position in GE HealthCare Technologies by 77.8% during the fourth quarter. Alhambra Investment Management LLC now owns 6,107 shares of the company’s stock valued at $472,000 after purchasing an additional 2,673 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in GE HealthCare Technologies by 59.3% in the fourth quarter. Assenagon Asset Management S.A. now owns 11,229 shares of the company’s stock valued at $868,000 after acquiring an additional 4,178 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 1.4 %

Shares of GEHC stock opened at $90.31 on Thursday. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The firm has a fifty day moving average of $84.70 and a 200-day moving average of $75.39. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50. The stock has a market cap of $41.12 billion, a price-to-earnings ratio of 29.90, a P/E/G ratio of 3.10 and a beta of 0.97.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business had revenue of $5.20 billion during the quarter, compared to the consensus estimate of $5.09 billion. During the same quarter last year, the company earned $1.31 EPS. GE HealthCare Technologies’s revenue was up 5.3% on a year-over-year basis. On average, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be issued a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.13%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is currently 3.97%.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and raised their target price for the company from $66.00 to $88.00 in a report on Monday, February 12th. Jefferies Financial Group assumed coverage on shares of GE HealthCare Technologies in a research report on Thursday, November 30th. They issued a “hold” rating and a $80.00 price target on the stock. Morgan Stanley lifted their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a report on Monday, February 12th. HSBC assumed coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price target on the stock. Finally, Mizuho raised their target price on GE HealthCare Technologies from $94.00 to $96.00 and gave the company a “buy” rating in a report on Wednesday, February 7th. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $88.73.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.